Answers are grounded in this paper and cite their sources.
Morbidity and mortality associated with cancer remain substantial global health challenges, underscoring the need for more effective prevention and treatment strategies. Recent advances in the molecular biology of endometrial cancer have facilitated the development of targeted therapies for advanced, recurrent, and post-surgical cases. Natural products offer a source of potential anticancer agents due to their structural and biological diversity. Centaurea lycaonica, a species endemic to Türkiye, has recently attracted interest in natural product research. Building upon our previous studies, which characterized the phytochemical profile of C. lycaonica and demonstrated its anticancer potential, this study evaluated the cytotoxic effects of dichloromethane (CHD) and methanol (CHM) extracts from its aerial parts on the RL95-2 human endometrial cancer cell line. Cytotoxic activity was assessed using the MTT assay and the xCELLigence real-time cell analysis (RTCA) system. The IC₅₀ values of CHM on RL95-2 cell viability at 48 h were determined as 125.20 µg/mL using MTT assay and 142.95 µg/mL using the xCELLigence RTCA system. In comparison, the IC₅₀ values of CHD were determined as 18.46 µg/mL and 13.91 µg/mL, respectively. The MTT assay results were consistent with those obtained using the xCELLigence RTCA system. Both extracts demonstrated concentration-dependent cytotoxic activity against RL95-2 cells, with CHD exhibiting greater cytotoxic activity than CHM. These findings indicate that C. lycaonica contains bioactive compounds with promising anticancer potential and support further investigation into its underlying mechanisms of action and the biological activities of other endemic plant species in Türkiye.
No takes yet. Share an insight, caveat, or question.
Arslan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: